RecruitingNot Applicable

Exploring the Nature, Assessment and Treatment of Stuttering

United States3,000 participantsStarted 2015-05-22

Plain-language summary

The purposes of this study are to 1) investigate potential speech, language, and psychosocial contributions to the experience of stuttering in monolingual and multilingual speakers, and to 2) evaluate interdisciplinary, telehealth, and speech-language pathology treatment methods and clinical training specific to fluency disorders.

Who can participate

Age range

2 Years – 85 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: A participant will be considered a child who stutters (ages 2-17 years) if * their parent/caregiver reports concern that their child is a person who stutters, * they exhibit three of more stuttering-like disfluencies (e.g., sound/syllable repetitions, (in)audible sound prolongations, whole-word repetitions) per 300-word speech sample, or * they present with an overall score of 11 or higher on the Stuttering Severity Instrument - 4th Edition (SSI-4). A participant will be considered an adult who stutters (18+ years) if * they report they are a person who stutters, * they have received a formal diagnosis of stuttering from a certified speech-language pathologist, * they exhibit three of more stuttering-like disfluencies (e.g., sound/syllable repetitions, (in)audible sound prolongations, whole-word repetitions) per 300-word speech sample, or * they present with an overall score of 11 or higher on the Stuttering Severity Instrument - 4th Edition (SSI-4). Exclusion Criteria: • There are no exclusion criteria for persons who stutter.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Communication Competence

Timeframe: 11-weeks

Advocacy

Timeframe: 11-weeks

Resilience

Timeframe: 11-weeks

Education

Timeframe: 11-weeks

Trial details

NCT IDNCT05908123

SponsorUniversity of Texas at Austin

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2035-05-22

Contact for this trial

Courtney T Byrd, PhD

512 475 6174 courtney.byrd@austin.utexas.edu

View on ClinicalTrials.gov More Stuttering trials

Plain-language summary

Who can participate

Age range

2 Years – 85 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.